Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipid Storage Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03759639
What this trial is testing

N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)

Who this might be right for
Niemann-Pick Disease, Type C
IntraBio Inc 33
Not applicableUnknownNCT04639999
What this trial is testing

Impact of MIgalastat TheRApy on CaRdiac Function in patiEnts With Fabry's Cardiomyopathy (MIRACRE-Fabry Trial)

Who this might be right for
Fabry Disease
Yonsei University 20
Not applicableStudy completedNCT00006057
What this trial is testing

Diagnostic and Screening Study of Genetic Disorders

Who this might be right for
Tay-Sachs DiseasePorphyria, ErythropoieticLeukodystrophy, Globoid Cell+1 more
National Center for Research Resources (NCRR) 50
Testing effectiveness (Phase 2)Study completedNCT00048906
What this trial is testing

Alpha-Galactosidase A Replacement Therapy for Fabry Disease

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 3
Testing effectiveness (Phase 2)UnknownNCT05710367
What this trial is testing

Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease Patients

Who this might be right for
Fabry Disease
Albina Nowak, MD 46
Large-scale testing (Phase 3)Study completedNCT03614234
What this trial is testing

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 29
Not applicableLooking for participantsNCT07495410
What this trial is testing

Anderson-Fabry Disease Fitness Improvement Training

Who this might be right for
Fabry Disease
General University Hospital, Prague 50
Not applicableUnknownNCT04893889
What this trial is testing

Substudy (NCT04456582): Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Two-dimensional Shear Wave Elastography) in Patients With Amyloidosis and Fabry Disease.

Who this might be right for
Fabry DiseaseAmyloidosis
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT05106764
What this trial is testing

Early Detection of Fabry Disease

Who this might be right for
Fabry Disease
Takeda 50
Not applicableLooking for participantsNCT06192576
What this trial is testing

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

Who this might be right for
Niemann-Pick DiseasesAcid Sphingomyelinase Deficiency
Sanofi 10
Not applicableEnded earlyNCT04008849
What this trial is testing

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

Who this might be right for
Inherited Metabolic Disorders (IMD)
Magenta Therapeutics, Inc. 3
Post-approval studies (Phase 4)Looking for participantsNCT05067868
What this trial is testing

Replagal in Children and Adults With Fabry Disease in India

Who this might be right for
Fabry Disease
Shire 5
Early research (Phase 1)Study completedNCT01747135
What this trial is testing

Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease

Who this might be right for
Niemann-Pick Disease, Type C1
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company 14
Not applicableStudy completedNCT04678713
What this trial is testing

Maximal Fat Oxidation and Fuel Use During Exercise

Who this might be right for
Obesity
University of Copenhagen 40
Testing effectiveness (Phase 2)Ended earlyNCT00526071
What this trial is testing

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Who this might be right for
Fabry Disease
Amicus Therapeutics 23
Testing effectiveness (Phase 2)Ended earlyNCT00668564
What this trial is testing

Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

Who this might be right for
Hurler's SyndromeMaroteaux-Lamy SyndromeSly Syndrome+8 more
Masonic Cancer Center, University of Minnesota 18
Not applicableUnknownNCT05904366
What this trial is testing

Magnetic Resonance Spectroscopy in Acid Sphingomyelinase Deficiency

Who this might be right for
Asmd, Visceral Type
Eline C. B. Eskes 34
Not applicableStudy completedNCT05046379
What this trial is testing

Studying Lipids as Potential Biomarkers in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Vastra Gotaland Region 108
Not applicableStudy completedNCT00151268
What this trial is testing

Genotype - Phenotype Correlations of LINCL

Who this might be right for
Batten DiseaseLate-Infantile Neuronal Ceroid Lipfuscinosis
Weill Medical College of Cornell University 18
Not applicableUnknownNCT01898325
What this trial is testing

Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan

Who this might be right for
Fibrosis
Rambam Health Care Campus 40
Next Page